Ten63 Therapeutics Secures $15.9M in Series A Financing
Summary
DURHAM, NC, Ten63 Therapeutics announced the closing of $15.9M in Series A financing. Ten63 Therapeutics, is a company combining generative AI and physics-based models to develop first- and best-in-class therapeutics, announced the closing of an oversubscribed $15.9 million Series A financing led by new investor Hatteras Venture Partners. Morpheus Ventures, SOSV, Draper Associates, Alexandria Venture Investments, the Sigma Group and other new investors also participated in the round. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected